A phase I clinical trial to evaluate the safety, tolerability, and pharmacodynamics of AST-005 in patients with chronic plaque psoriasis

Trial Profile

A phase I clinical trial to evaluate the safety, tolerability, and pharmacodynamics of AST-005 in patients with chronic plaque psoriasis

Completed
Phase of Trial: Phase I

Latest Information Update: 12 Dec 2016

At a glance

  • Drugs AST 005 (Primary)
  • Indications Plaque psoriasis
  • Focus Adverse reactions
  • Most Recent Events

    • 12 Dec 2016 According to a Purdue Pharma media release, status changed from recruiting to completed.
    • 29 Apr 2016 New trial record
    • 26 Apr 2016 Topline results from trial trial are expected later this year, according to an Exicure media release.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top